ModivCare Stock Forecast for 2023 - 2025 - 2030
Updated on 05/10/2024
ModivCare Stock Forecast and Price Target
ModivCare's stock price reaches the average target of $43.00 by 2025 as expected recently by three notable experts, there would be a potential upside of approximately 63.81% from the last closing price in May, 2024. This possible increase is based on a high estimate of $75.00 and a low estimate of $25.00. If you are looking to invest in the stock, it's important to research and compare different companies.
63.81% Upside
ModivCare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, ModivCare's Price has seen a drop from $131.70 to $0.00 – a 100.00% decrease. Next year, analysts are expecting Fair Value to reach $124.88 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IBM Stock Forecast | International Business Machine... | Hold |
7
|
$167.15 | Buy/Sell | $175.67 | 12.17% |
| UBER Stock Forecast | Uber Technologies | Buy |
14
|
$66.99 | Buy/Sell | $65.86 | 32.86% |
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$202.92 | Buy/Sell | $219.12 | 8.91% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$82.84 | Buy/Sell | $92.47 | 15.89% |
| DXCM Stock Forecast | DexCom Inc | Buy |
12
|
$127.05 | Buy/Sell | $125.98 | 18.91% |
ModivCare Revenue Forecast for 2023 - 2025 - 2030
In the last three years, ModivCare's Revenue has grown from $1.37B to $2.75B – a 101.01% increase. Next year, analysts are expecting Revenue to reach $2.91B – an increase of 5.80%. Over the next eight years, the forecast is for Revenue to grow by 17.12%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| T Stock Forecast | TELUS | Outperform |
18
|
C$22.01 | Buy/Sell | C$28.53 | 15.86% |
| 9613 Stock Forecast | NTT DATA Group | Outperform |
18
|
¥2.30k | Buy/Sell | ¥2.45k | 8.65% |
| LYFT Stock Forecast | Lyft | Hold |
6
|
$17.18 | Buy/Sell | $12.33 | 4.77% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MMS Stock Forecast | Maximus | Outperform |
18
|
$84.76 | Buy/Sell | $100.33 | 23.88% |
| SRP Stock Forecast | Serco Group | Buy |
18
|
£1.85 | Buy/Sell | £2.21 | 18.92% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$25.99 | Buy/Sell | $46.60 | -1.89% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$14.64 | Buy/Sell | $18.00 | 36.61% |
| CPI Stock Forecast | Capita | Outperform |
10
|
£0.15 | Buy/Sell | £0.38 | 80.00% |
| ATO Stock Forecast | Atos | Underperform |
14
|
2.00€ | Buy/Sell | 14.92€ | 0.00% |
ModivCare EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, ModivCare's EBITDA has decreased from $166.04M to $142.39M – a 14.24% drop. In the next year, analysts believe that EBITDA will reach $224.25M – an increase of 57.49%. For the next seven years, the forecast is for EBITDA to grow by 76.82%.
ModivCare EBIT Forecast for 2023 - 2025 - 2030
In the last three years, ModivCare's EBIT has decreased by 72.74%, going from $139.86M to $38.12M. In the next year, analysts believe that EBIT will reach $96.92M – an increase of 154.25%. For the next eight years, experts predict that ModivCare's EBIT will grow at a rate of 245.18%.
ModivCare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, ModivCare's EPS has seen a drop from $6.95 to $0.00 – a 100.00% decrease. Next year, analysts are expecting EPS to reach $6.59 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)